SUMMARY. Encapsulation of purified tuberculoproteins in liposomes augmented their ability to elicit delayed hypersensitivity reactions in BCG-immune rats. The effect was most marked with a low-molecular-weight tuberculopeptide that was relatively poor at eliciting reactions when in free form. These findings indicate that, in addition to the antigenic nature of the material, the physical form of presentation of mycobacterial test antigens can influence their ability to elicit hypersensitivity reactions.
INTRODUCTION
Tuberculins, either as crude materials such as Old Tuberculin or as relatively more purified preparations such as Purified Protein Derivative, elicit delayed-type hypersensitivity (DTH) reactions in many animal species immunised with a wide variety of mycobacteria (Gupta and Landi, 1978; Rosenthal, 1980) . This DTH reaction is of value in the diagnosis of tuberculosis but does not necessarily indicate pre-existing immunity to the disease (Rosenthal, 1980) . DTH-eliciting potency has also been used to determine the minimal structure necessary for a tuberculoprotein to retain antigenicity (Gupta and Landi, 1978; Landi, Held and Tseng, 1970; Kuwabara, 1975) . However, this latter type of assay requires testing of preparations of a wide range of materials with molecular weights between a few thousand and several millions. It is possible that in these circumstances the extent of retention at, and rate of clearance from, dermal injection sites may vary and this may influence the extent of the DTH reaction in addition to the antigenic nature of the material. Examination of the anti-tumour effects of DTH reactions to tuberculin preparations showed that liposomal encapsulation may greatly enhance the ability of antigens to elicit DTH reactions in appropriately sensitised animals (Pimm and Baldwin, 1984) . Observations of this phenomenon are reported here.
MATERIALS AND METHODS

Antigens.
A purified protein derivative designated PPD-CT68 isolated by trichloracetic acid precipitation from the culture filtrate of Mycobacterium tuberculosis "Johnston" strain (Landi and Held, 1980) and a mixture of low-mol. wt (3000-12000) peptides prepared from PPD-CT68 by enzymatic hydrolysis (Gupta and Landi, 1978) and designated Purified Tuberculin Peptide (PTP), were supplied by Professor S. Landi, Tuberculosis Division, Connaught Medical Laboratories, Canada. Solutions of PTP and PPD-CT68 were prepared in phosphate buffered saline, pH 7.2 (PBS) and stored at -20°C. To allow quantitation of liposomal encapsulation, PPD and PTP were labelled with lZ5I by an Iodogen technique; unbound iodine was separated by gel filtration on Sephadex G-25 (Pimm et al., 1982) .
Test animals. Female WAB/Not rats were immunised with Glaxo BCG vaccine BP. This vaccine was reconstituted from its lyophilised state by the addition of 0.3 ml of water for injection BP to each ampoule, and 0.1 ml, containing 1 mg moist weight of organisms, was injected intramuscularly into a hind limb.
Liposomal encapsulation. Liposomes containing PPD-CT68 or PTP were prepared from phosphatidylcholine (PC) and phosphatidylserine (PS) (Sigma Chemical Co., Ltd, Poole, Dorset). Mixtures of PC (in hexane) and PS (in chloroform : methanol, 95 : 5) at molar ratios of 7:3 were evaporated to dryness in glass tubes under a stream of nitrogen. Solutions of PPD-CT68 or PTP at between 1 and 5 mg/ml were added to the dried lipid at ratios of between 5 and 40 mg of lipid/ml of solution and liposomes generated by brief vortex agitation. Free PPD-CT68 or PTP were removed by gel filtration on Sepharose 4B (Pharmacia, Uppsala, Sweden) (column dimensions 1.5 x 20 cm) with elution in PBS. The amount of entrapped material was determined from the 1251 count. About 10% of the PPD-CT68 or PTP was associated with the final preparations, which contained up to 20 pg of antigen/mg of liposomal lipid. Skin tests. DTH reactions to free or liposomally-encapsulated antigens were examined after intradermal injection in the ears of rats immunised 14 days previously with BCG. Each antigen (50 pl) was injected intradermally with a 22 g needle into the pinna of one ear; the contralateral ear received 50 pl of PBS. Ear thicknesses were measured with a micrometer 24 h later. For each rat the percent increase in ear thickness was calculated from this formula: thickness (mm) of test ear -thickness of control ear thickness of control ear
Six sets of tests were done with four sets of concentrations and proportions of PPD-CT68 and lipid and two sets of concentrations and proportions of PTP and lipid (table) . The mean percentage increase was calculated for groups of 3-4 rats, and statistical significance of the difference between groups calculated from Student's t test. Delayed hypersensitivity reactions of BCG-immune rats to the tuberculoproteins PPD-CT68 and PTP.
RESULTS
PTP was quantitatively inferior to PPD-CT68 in eliciting DTH reactions in the ears of
BCG-immune rats (fig).
Thus a response was seen with as little as 0.15 pg of PPD-CT68 compared with at least 2-5 pg of PTP. However, with both preparations liposomal encapsulation augmented their ability to elicit DTH reactions (table) . For example, in test 1, 0.12 pg of PPD-CT68 encapsulated in liposomes gave virtually the maximum DTH reaction, whereas a similar reaction required 2.0 pg of free PPD-CT68, and in test 2, liposomal encapsulated PPD-CT68 was again superior. Free liposomes gave minimal reactions in BCG-immune rats (test 3) and neither free nor liposomal PPD-CT68 gave significant reactions in unimmunised rats (test 4) although liposomal encapsulation again enhanced reactions in BCG-immune animals. In tests with PTP (tests 5 and 6), liposomal encapsulation markedly improved the DTH-eliciting potency. Ear thickening of up to 81% was seen with 0.3 pg of liposomal PTP (test 5 ) but free PTP, even at doses of 5 pg, did not give such marked reactions (fig; table, tests 5 and 6): In test 6, the DTH reaction elicited by 0.05 pg of liposomally-encapsulated PTP (24% ear thickening) was similar to that seen with one hundred times as much free PTP (17% ear thickening).
DISCUSSION
Although liposomal encapsulation is well established as a means of altering the biodistribution of drugs and immune modulating agents (Gregoriadis, 1976; Eppstein, 1982; Poste et al., 1982) and can act as an adjuvant in the development of immune responses to antigens (Gregoriadis, 1976; Heath, Edwards and Ryman, 1976 ) the encapsulation of antigens for eliciting hypersensitivity reactions in immune individuals does not seem to have been investigated. In examining the Arthus reaction to diphtheria toxin in mice, Gregoriadis and Allison (1974) observed that liposomal encapsulation did not interfere with induction of hypersensitivity, but liposomally-encapsulated antigen was relatively poor at eliciting the reaction. In that situation, presumably, liposomally-encapsulated antigen was poorly available for interaction with circulating antibody. In the present study, one interpretation of enhanced DTH reactions to liposomally-encapsulated antigen is facilitation of cellular recognition of the antigen, although whether this depends simply upon longer local retention of the antigen or its altered cellular handling or recognition is not known.
The rat was used as the experimental model because these studies arose out of an
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investigation of the effects of DTH reactions on the growth of rat mammary carcinomas (Pimm and Baldwin, 1984) . Whether similar augmention of DTH reactions is seen in other species, e.g., guinea pigs, has not been evaluated, but the indication from the present findings is that the physical form of presentation of an antigen can influence its ability to elicit DTH reactions, and this has implications for the in-vivo assay of DTH-eliciting antigens. Negatively charged liposomes of relatively simple composition were used. It is well established that alteration of size and charge of liposomes will alter their biodistribution and survival (Fidler et al., 1980 ) and encapsulation of antigens in different liposome structures may give even more heightened DTH reactions. Moreover, other biological responses to tuberculoproteins may be altered by liposomal encapsulation. For example, Burleson, Kulpa and Germain-De Matteis (1982) have demonstrated that liposomally-encapsulated Old Tuberculin is a potent inducer of interferon in mice,whereas the free material is virtually inactive.
In conclusion, these studies indicate that liposomal encapsulation of tuberculoproteins augments their ability to elicit DTH reactions. This suggests that similar encapsulation of other sensitising antigens may similarly augment DTH responses, and this may be of value in identifying antigenic components of microorganisms that elicit DTH reactions. This work was supported by a grant from the Cancer Research Campaign, London. Tuberculin preparations were a gift from Professor S. Landi, and BCG was from Glaxo Group Research.
